{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:42:42Z","timestamp":1791420162093,"version":"4.3.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Coronary heart disease (CHD) is one of the leading causes of death. Alarmingly Iranian populations had a high rank of CHD worldwide. The current study aimed to assess the prevalence of CHD across different glycemic categories.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study was conducted on 7718 Tehranian participants (Men\u2009=\u20093427) aged \u226530\u2009years from 2008 to 2011. They were categorized based on glycemic status. The prevalence of CHD was calculated in each group separately. CHD was defined as hospital records adjudicated by an outcome committee. The association of different glycemic categories with CHD was calculated using multivariate logistic regression, compared with normal fasting glucose \/normal glucose tolerance (NFG\/NGT) group as reference.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The age-standardized prevalence of isolated impaired fasting glucose (iIFG), isolated impaired glucose tolerance (iIGT), both impaired fasting glucose and impaired glucose tolerance (IFG\/IGT), newly diagnosed diabetes mellitus (NDM), and known diabetes mellitus (KDM) were 14.30% [95% confidence interval (CI): 13.50\u201315.09], 4.81% [4.32\u20135.29], 5.19% [4.71\u20135.67], 5.79% [5.29\u20136.28] and 7.72% [7.17\u20138.27], respectively.<\/jats:p>\n                    <jats:p>Among a total of 750 individuals diagnosed as cases of CHD (398 in men), 117 (15.6%), 453 (60.4%), and 317 (42.3%) individuals had a history of myocardial infarction (MI), cardiac procedure, and unstable angina, respectively. The age-standardized prevalence of CHD for the Tehranian population was 7.71% [7.18\u20138.24] in the total population, 8.62 [7.81\u20139.44] in men and 7.19 [6.46\u20137.93] in women. Moreover, among diabetic participants, the age-standardized prevalence of CHD was 13.10 [9.83\u201316.38] in men and 10.67 [8.90\u201312.44] in women, significantly higher than corresponding values for NFG\/NGT and prediabetic groups.<\/jats:p>\n                    <jats:p>Across six levels of glycemic status, CHD was associated with IFG\/IGT [odds ratio (OR) and 95% CI: 1.38 (1.01\u20131.89)], NDM [1.83 (1.40\u20132.41)], and KDM [2.83 (2.26\u20133.55)] groups, in the age- and sex-adjusted model. Furthermore, in the full-adjusted model, only NDM and KDM status remained to be associated with the presence of CHD by ORs of 1.40 (1.06\u20131.86) for NDM and 1.91 (1.51\u20132.43) for KDM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The high prevalence of CHD, especially among diabetic populations, necessitates the urgent implementation of behavioral interventions in the Tehranian population, according to evidence-based guidelines for the clinical management of diabetic patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-020-09595-4","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T15:02:54Z","timestamp":1601996574000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Sex-specific prevalence of coronary heart disease among Tehranian adult population across different glycemic status: Tehran lipid and glucose study, 2008\u20132011"],"prefix":"10.1186","volume":"20","author":[{"given":"Seyyed Saeed","family":"Moazzeni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidreza","family":"Ghafelehbashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitra","family":"Hasheminia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Parizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Ghanbarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereidoun","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8935-2744","authenticated-orcid":false,"given":"Farzad","family":"Hadaegh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,6]]},"reference":[{"issue":"10159","key":"9595_CR1","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","volume":"392","author":"GA Roth","year":"2018","unstructured":"Roth GA, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1736\u201388.","journal-title":"Lancet."},{"key":"9595_CR2","volume-title":"Global and regional causes of death: patterns and trends, 2000\u201315","author":"C Mathers","year":"2017","unstructured":"Mathers C, Stevens G, Hogan D, Mahanani WR, Ho J. Global and regional causes of death: patterns and trends, 2000\u201315; 2017."},{"issue":"1","key":"9595_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.26719\/2009.15.1.157","volume":"15","author":"F Hadaegh","year":"2009","unstructured":"Hadaegh F, Harati H, Ghanbarian A, Azizi F. Prevalence of coronary heart disease among Tehran adults: Tehran lipid and glucose study. East Mediterr Health J. 2009;15(1):157\u201366.","journal-title":"East Mediterr Health J"},{"issue":"8","key":"9595_CR4","doi-asserted-by":"publisher","first-page":"e105804","DOI":"10.1371\/journal.pone.0105804","volume":"9","author":"D Khalili","year":"2014","unstructured":"Khalili D, Sheikholeslami FH, Bakhtiyari M, Azizi F, Momenan AA, Hadaegh F. The incidence of coronary heart disease and the population attributable fraction of its risk factors in Tehran: a 10-year population-based cohort study. PLoS One. 2014;9(8):e105804.","journal-title":"PLoS One"},{"issue":"12","key":"9595_CR5","doi-asserted-by":"publisher","first-page":"e0167623","DOI":"10.1371\/journal.pone.0167623","volume":"11","author":"M Sardarinia","year":"2016","unstructured":"Sardarinia M, Akbarpour S, Lotfaliany M, Bagherzadeh-Khiabani F, Bozorgmanesh M, Sheikholeslami F, et al. Risk factors for incidence of cardiovascular diseases and all-cause mortality in a middle eastern population over a decade follow-up: Tehran lipid and glucose study. PLoS One. 2016;11(12):e0167623.","journal-title":"PLoS One"},{"issue":"9733","key":"9595_CR6","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","volume":"375","author":"Collaboration ERF","year":"2010","unstructured":"Collaboration ERF. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215\u201322.","journal-title":"Lancet."},{"issue":"4","key":"9595_CR7","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1536\/ihj.17-191","volume":"58","author":"R Naito","year":"2017","unstructured":"Naito R, Miyauchi K. Coronary artery disease and type 2 diabetes mellitus. Int Heart J. 2017;58(4):475\u201380.","journal-title":"Int Heart J"},{"issue":"1","key":"9595_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1745-6215-10-5","volume":"10","author":"F Azizi","year":"2009","unstructured":"Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran lipid and glucose study phase II. Trials. 2009;10(1):5.","journal-title":"Trials."},{"issue":"11","key":"9595_CR9","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.2337\/diacare.26.11.3160","volume":"26","author":"S Genuth","year":"2003","unstructured":"Genuth S, Alberti K, Bennett P, Buse J, Defronzo R, Kahn R, et al. Follow-up report on the diagnosis of diabetes mellitus. The expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26(11):3160\u20137.","journal-title":"Diabetes Care"},{"issue":"2","key":"9595_CR10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.diabres.2013.12.034","volume":"103","author":"A Esteghamati","year":"2014","unstructured":"Esteghamati A, Etemad K, Koohpayehzadeh J, Abbasi M, Meysamie A, Noshad S, et al. Trends in the prevalence of diabetes and impaired fasting glucose in association with obesity in Iran: 2005-2011. Diabetes Res Clin Pract. 2014;103(2):319\u201327.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"9595_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/dme.13034","volume":"34","author":"F Hadaegh","year":"2017","unstructured":"Hadaegh F, Derakhshan A, Zafari N, Khalili D, Mirbolouk M, Saadat N, et al. Pre-diabetes tsunami: incidence rates and risk factors of pre-diabetes and its different phenotypes over 9 years of follow-up. Diabet Med. 2017;34(1):69\u201378.","journal-title":"Diabet Med"},{"issue":"4 Suppl","key":"9595_CR12","first-page":"e84777","volume":"16","author":"F Azizi","year":"2018","unstructured":"Azizi F, Zadeh-Vakili A, Takyar M. Review of rationale, design, and initial findings: Tehran lipid and glucose study. Int J Endocrinol Metab. 2018;16(4 Suppl):e84777.","journal-title":"Int J Endocrinol Metab"},{"issue":"19","key":"9595_CR13","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","volume":"289","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. Jama. 2003;289(19):2560\u201371.","journal-title":"Jama."},{"key":"9595_CR14","volume-title":"Guidelines for data processing and analysis of the International Physical Activity Questionnaire (IPAQ)-short and long forms","author":"IR Committee","year":"2005","unstructured":"Committee IR. Guidelines for data processing and analysis of the International Physical Activity Questionnaire (IPAQ)-short and long forms. http:\/\/www.ipaq.ki.se\/scoring.pdf. 2005."},{"key":"9595_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-020-01017-4","volume":"19","author":"M Kabootari","year":"2020","unstructured":"Kabootari M, Hasheminia M, Azizi F, Mirbolouk M, Hadaegh F. Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran lipid and glucose study. Cardiovasc Diabetol. 2020;19:1\u201311.","journal-title":"Cardiovasc Diabetol"},{"issue":"20","key":"9595_CR16","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1161\/01.CIR.0000100560.46946.EA","volume":"108","author":"RV Luepker","year":"2003","unstructured":"Luepker RV, Apple FS, Christenson RH, Crow RS, Fortmann SP, Goff D, et al. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation. 2003;108(20):2543\u20139.","journal-title":"Circulation"},{"issue":"2","key":"9595_CR17","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.amepre.2018.09.022","volume":"56","author":"KE Moran","year":"2019","unstructured":"Moran KE, Ommerborn MJ, Blackshear CT, Sims M, Clark CR. Financial stress and risk of coronary heart disease in the Jackson heart study. Am J Prev Med. 2019;56(2):224\u201331.","journal-title":"Am J Prev Med"},{"issue":"4 Suppl 6","key":"9595_CR18","first-page":"S6","volume":"15","author":"E Keku","year":"2005","unstructured":"Keku E, Rosamond W, Taylor HA Jr, Garrison R, Wyatt SB, Richard M, et al. Cardiovascular disease event classification in the Jackson heart study: methods and procedures. Ethn Dis. 2005;15(4 Suppl 6):S6\u201362.","journal-title":"Ethn Dis"},{"issue":"1","key":"9595_CR19","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/1471-2458-8-176","volume":"8","author":"F Hadaegh","year":"2008","unstructured":"Hadaegh F, Bozorgmanesh MR, Ghasemi A, Harati H, Saadat N, Azizi F. High prevalence of undiagnosed diabetes and abnormal glucose tolerance in the Iranian urban population: Tehran lipid and glucose study. BMC Public Health. 2008;8(1):176.","journal-title":"BMC Public Health"},{"issue":"2","key":"9595_CR20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.gheart.2018.01.001","volume":"13","author":"M Abbasi","year":"2018","unstructured":"Abbasi M, Neishaboury M, Koohpayehzadeh J, Etemad K, Meysamie A, Asgari F, et al. National Prevalence of Self-Reported Coronary Heart Disease and Chronic Stable Angina Pectoris: Factor Analysis of the Underlying Cardiometabolic Risk Factors in the SuRFNCD-2011. Glob Heart. 2018;13(2):73\u201382.e71.","journal-title":"Glob Heart"},{"issue":"10","key":"9595_CR21","doi-asserted-by":"publisher","first-page":"184","DOI":"10.24095\/hpcdp.35.10.02","volume":"35","author":"C Blais","year":"2015","unstructured":"Blais C, Rochette L. Trends in prevalence, incidence and mortality of diagnosed and silent coronary heart disease in Quebec. Health Promot Chronic Dis Prev Can. 2015;35(10):184\u201393.","journal-title":"Health Promot Chronic Dis Prev Can"},{"issue":"10","key":"9595_CR22","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","volume":"139","author":"EJ Benjamin","year":"2019","unstructured":"Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke Statistics-2019 update: a report from the American Heart Association. Circulation. 2019;139(10):e56\u2013e528.","journal-title":"Circulation."},{"issue":"24","key":"9595_CR23","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1136\/heartjnl-2016-309573","volume":"102","author":"P Bhatnagar","year":"2016","unstructured":"Bhatnagar P, Wickramasinghe K, Wilkins E, Townsend N. Trends in the epidemiology of cardiovascular disease in the UK. Heart. 2016;102(24):1945\u201352.","journal-title":"Heart."},{"issue":"2","key":"9595_CR24","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.aogh.2016.04.002","volume":"82","author":"R Gupta","year":"2016","unstructured":"Gupta R, Mohan I, Narula J. Trends in coronary heart disease epidemiology in India. Ann Glob Health. 2016;82(2):307\u201315.","journal-title":"Ann Glob Health"},{"issue":"9","key":"9595_CR25","first-page":"1165","volume":"25","author":"M Al-Nozha","year":"2004","unstructured":"Al-Nozha M, Arafah M, Al-Mazrou Y, Al-Maatouq M, Khan N, Khalil M, et al. Coronary artery disease in Saudi Arabia. Saudi Med J. 2004;25(9):1165\u201371.","journal-title":"Saudi Med J"},{"issue":"5","key":"9595_CR26","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1177\/2047487315587402","volume":"23","author":"K-F Zhu","year":"2016","unstructured":"Zhu K-F, Wang Y-M, Zhu J-Z, Zhou Q-Y, Wang N-F. National prevalence of coronary heart disease and its relationship with human development index: a systematic review. Eur J Prev Cardiol. 2016;23(5):530\u201343.","journal-title":"Eur J Prev Cardiol"},{"key":"9595_CR27","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.scitotenv.2019.01.182","volume":"661","author":"A Khajavi","year":"2019","unstructured":"Khajavi A, Khalili D, Azizi F, Hadaegh F. Impact of temperature and air pollution on cardiovascular disease and death in Iran: a 15-year follow-up of Tehran lipid and glucose study. Sci Total Environ. 2019;661:243\u201350.","journal-title":"Sci Total Environ"},{"issue":"19","key":"9595_CR28","doi-asserted-by":"publisher","first-page":"14651","DOI":"10.1007\/s11356-015-5188-x","volume":"22","author":"C Luo","year":"2015","unstructured":"Luo C, Zhu X, Yao C, Hou L, Zhang J, Cao J, et al. Short-term exposure to particulate air pollution and risk of myocardial infarction: a systematic review and meta-analysis. Environ Sci Pollut Res Int. 2015;22(19):14651\u201362.","journal-title":"Environ Sci Pollut Res Int"},{"key":"9595_CR29","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1146\/annurev-publhealth-031912-114452","volume":"34","author":"A Steptoe","year":"2013","unstructured":"Steptoe A, Kivimaki M. Stress and cardiovascular disease: an update on current knowledge. Annu Rev Public Health. 2013;34:337\u201354.","journal-title":"Annu Rev Public Health"},{"issue":"1","key":"9595_CR30","doi-asserted-by":"publisher","first-page":"13461","DOI":"10.1038\/s41598-017-13379-z","volume":"7","author":"A Esteghamati","year":"2017","unstructured":"Esteghamati A, Larijani B, Aghajani MH, Ghaemi F, Kermanchi J, Shahrami A, et al. Diabetes in Iran: prospective analysis from first Nationwide diabetes report of National Program for prevention and control of diabetes (NPPCD-2016). Sci Rep. 2017;7(1):13461.","journal-title":"Sci Rep"},{"issue":"9","key":"9595_CR31","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.1210\/jc.2018-00422","volume":"103","author":"Y Lyu","year":"2018","unstructured":"Lyu Y, Luo Y, Li C, Guo X, Lu J, Wu H, et al. Regional differences in the prevalence of coronary heart disease and stroke in patients with type 2 diabetes in China. J Clin Endocrinol Metab. 2018;103(9):3319\u201330.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"9595_CR32","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12872-018-0887-0","volume":"18","author":"B Sakboonyarat","year":"2018","unstructured":"Sakboonyarat B, Rangsin R. Prevalence and associated factors of ischemic heart disease (IHD) among patients with diabetes mellitus: a nation-wide, cross-sectional survey. BMC Cardiovasc Disord. 2018;18(1):151.","journal-title":"BMC Cardiovasc Disord"},{"issue":"3","key":"9595_CR33","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.diabres.2007.10.009","volume":"79","author":"AB Wirehn","year":"2008","unstructured":"Wirehn AB, Ostgren CJ, Carstensen JM. Age and gender differences in the impact of diabetes on the prevalence of ischemic heart disease: a population-based register study. Diabetes Res Clin Pract. 2008;79(3):497\u2013502.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"9595_CR34","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.diabres.2006.10.014","volume":"77","author":"WJ Kalk","year":"2007","unstructured":"Kalk WJ, Joffe BI. Differences in coronary heart disease prevalence and risk factors in African and white patients with type 2 diabetes. Diabetes Res Clin Pract. 2007;77(1):107\u201312.","journal-title":"Diabetes Res Clin Pract"},{"issue":"12","key":"9595_CR35","doi-asserted-by":"publisher","first-page":"e112639","DOI":"10.1371\/journal.pone.0112639","volume":"9","author":"Y Jahangiri-Noudeh","year":"2014","unstructured":"Jahangiri-Noudeh Y, Akbarpour S, Lotfaliany M, Zafari N, Khalili D, Tohidi M, et al. Trends in cardiovascular disease risk factors in people with and without diabetes mellitus: a middle eastern cohort study. PLoS One. 2014;9(12):e112639.","journal-title":"PLoS One"},{"issue":"1","key":"9595_CR36","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1475-2840-9-84","volume":"9","author":"F Hadaegh","year":"2010","unstructured":"Hadaegh F, Fahimfar N, Khalili D, Sheikholeslami F, Azizi F. New and known type 2 diabetes as coronary heart disease equivalent: results from 7.6 year follow up in a Middle East population. Cardiovasc Diabetol. 2010;9(1):84.","journal-title":"Cardiovasc Diabetol"},{"issue":"7","key":"9595_CR37","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1056\/NEJMoa1800256","volume":"379","author":"A Rawshani","year":"2018","unstructured":"Rawshani A, Rawshani A, Franz\u00e9n S, Sattar N, Eliasson B, Svensson AM, et al. Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2018;379(7):633\u201344.","journal-title":"N Engl J Med"},{"issue":"3","key":"9595_CR38","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s12020-009-9261-4","volume":"36","author":"Q Yan","year":"2009","unstructured":"Yan Q, Gu WQ, Hong J, Zhang YF, Su YX, Gui MH, et al. Coronary angiographic studies of impaired glucose regulation and coronary artery disease in Chinese nondiabetic subjects. Endocrine. 2009;36(3):457\u201363.","journal-title":"Endocrine."},{"issue":"4 Suppl","key":"9595_CR39","first-page":"e84778","volume":"16","author":"M Barzin","year":"2018","unstructured":"Barzin M, Valizadeh M, Serahati S, Mahdavi M, Azizi F, Hosseinpanah F. Overweight and obesity: findings from 20 years of the Tehran lipid and glucose study. Int J Endocrinol Metab. 2018;16(4 Suppl):e84778.","journal-title":"Int J Endocrinol Metab"},{"issue":"1","key":"9595_CR40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.5334\/gh.780","volume":"15","author":"S Asgari","year":"2020","unstructured":"Asgari S, Moazzeni SS, Azizi F, Abdi H, Khalili D, Hakemi MS, et al. Sex-specific incidence rates and risk factors for hypertension during 13 years of follow-up: the Tehran lipid and glucose study. Glob Heart. 2020;15(1):29.","journal-title":"Glob Heart"},{"issue":"1","key":"9595_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1123\/jpah.8.1.27","volume":"8","author":"A Esteghamati","year":"2011","unstructured":"Esteghamati A, Khalilzadeh O, Rashidi A, Kamgar M, Meysamie A, Abbasi M. Physical activity in Iran: results of the third national surveillance of risk factors of non-communicable diseases (SuRFNCD-2007). J Phys Act Health. 2011;8(1):27\u201335.","journal-title":"J Phys Act Health"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-020-09595-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-020-09595-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-020-09595-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T02:22:37Z","timestamp":1633486957000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-020-09595-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,6]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["9595"],"URL":"https:\/\/doi.org\/10.1186\/s12889-020-09595-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.20006\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.20006\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.20006\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.20006\/v4","asserted-by":"object"}]},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,6]]},"assertion":[{"value":"11 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was passed by the Institutional Review Board (IRB) of the Research Institute for Endocrine Sciences (RIES), Shahid Beheshti University of Medical Sciences. Written informed consent was provided for all participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1510"}}